| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Weaver Kirke | Gen. Counsel & Corp. Secy. | C/O ORGANON & CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY | /s/ Faye C. Brown, as Attorney-in-Fact for Kirke Weaver | 03 Mar 2026 | 0001959622 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Award | $0 | +21,925 | +42% | $0.000000 | 74,414 | 27 Feb 2026 | Direct | F1 |
| transaction | OGN | Common Stock | Tax liability | $48,864 | -6,815 | -9.2% | $7.17 | 67,599 | 27 Feb 2026 | Direct | |
| transaction | OGN | Common Stock | Award | $0 | +6,186 | +9.2% | $0.000000 | 73,785 | 27 Feb 2026 | Direct | F2 |
| transaction | OGN | Common Stock | Tax liability | $12,746 | -1,763 | -2.3% | $7.23 | 73,854 | 27 Feb 2026 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 11, 2023 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors. |
| F2 | Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above. |
| F3 | Includes the addition of 1,832.163 shares of Common Stock acquired from dividend equivalents not previously required to be reported. |
Exhibit 24 - Power of Attorney